GlaxoSmithKline plc

GSK is accused of paying kickbacks to doctors to gain their support for their drugs
A woman works on a vaccine production line at a GlaxoSmithKline plant in France
GSK added in a statement that group revenue rose 1.0 percent to £6.64 billion in the first three months of 2012
GlaxoSmithKline is one of the world's largest drugmakers
David Cameron is to boost funding for treatments and cures for dementia
A GlaxoSmithKline logo is seen outside one of its buildings in west London, ahead of company results
James Murdoch has decided against seeking re-election as a non-executive director at GSK
Diabetes Drug Safety Study
Diabetes Pill FDA
Glaxo Pfizer GAVI
Glaxo Pfizer GAVI
Denture Cream Zinc
Denture Cream Zinc
Britain Earns GlaxoSmithKline
Glaxo Fighting Malaria
Glaxo Fighting Malaria
Glaxo Fighting Malaria
Vaccine Revolution
Drug Companies Online Ads
Drug Companies Online Ads

Malaria vaccine fails to work after four years: study

A new vaccine that has raised hopes of becoming a potent new tool in the battle against malaria seems to stop working in children after four years, according to research published Wednesday.
 

British business backs PM's foreign aid pledge

Chief executives of some of Britain's biggest companies -- including BP, Vodafone and GlaxoSmithKline -- on Monday joined the boss of English football's Premier League in stressing the need for Britain to maintain its overseas aid budget.
 

Drugmaker GSK reveals lower profits, restructuring

British drugs firm GlaxoSmithKline on Wednesday unveiled a 13-percent drop in annual net profits and outlined a plan for more restructuring in Europe to deliver greater savings and offset weaker sales across the region.
 

GlaxoSmithKline plans revamp as profits drop

British drugmaker GlaxoSmithKline on Wednesday announced a 13-percent drop in annual profits and said it would further restructure its European operations to deliver greater savings amid weaker sales across the region.
 

London shares tumble after Barclays resignations

.London shares tumbled on Monday as the resignation of two Barclays directors added to gloom about scandals in the UK banking sector
 

FTSE ends higher on US, manufacturing data

London shares closed higher on Friday on reassuring US jobs data and a slight expansion in UK manufacturing in January.
 

Didier Jambart Claims Drug Requip Turned Him Into A Gay Sex Addict

Glaxo has been ordered to pay $250,000 in damages to a man who claims Requip turned him into a gay sex addict. A French court has ordered British pharmaceutical giant GlaxoSmithKline to pay $250,000 in damages to Didier Jambart, who claims the manufacturer's Requip, also known as Ropinirole, turned him into a gay sex and gambling addict. Jambart, a 52-year-old married father of two, began taking the drug in 2003 to treat his Parkinson's symptoms. While taking the drug, Jambart claims he developed wild urges for online gambling and anonymous sexual encounters with men. ?It's a great day,? Jambart is quoted as saying by the AFP. ?It's been a seven-year battle with our limited means for recognition of the fact that GSK lied to us and shattered our lives.? Jambart said he became suicidal after he gambled this family's life savings, and tried to kill himself eight times. He also began cross-dressing. He said he was raped during an illicit encounter he had arranged. A 2010 study published in
 

London shares close flat amid 'fiscal cliff' fears

London shares closed flat on Wednesday amid renewed concern about the looming "fiscal cliff" of automatic tax rises and spending cuts which threatens to send the United States back into recession, dealers said.
 

Glaxo loses 'gay sex addict' court appeal

A French appeals court Wednesday upheld a ruling ordering British pharmaceutical giant GlaxoSmithKline to pay 197,000 euros to a man who claimed that its drug to treat Parkinson's turned him into a gay sex and gambling addict.
 

French court upholds GSK Parkinson's drug ruling

A French appeals court Wednesday upheld a ruling ordering pharmaceutical giant GlaxoSmithKline to pay 197,000 euros to a man who claimed that its drug to treat Parkinson's turned him into a gay sex and gambling addict.
 

GSK unveils expansion plans in India, Nigeria

British drugmaker GlaxoSmithKline said it intends to increase its holdings in its Indian and Nigerian divisions, as part of a long-term strategy to expand into emerging markets, in a statement on Monday.
 

GSK bids $940 million to hike stake in Indian unit

Britain's GlaxoSmithKline announced on Monday a $940-million bid to sharply increase its stake in its Indian consumer products unit, sending shares of the local company to a record high.
 

World anti-doping agency says 'lacks funding'

The World Anti-Doping Agency (WADA) on Monday called for wider efforts to tackle the use of banned substances in sport, warning that lack of funding was hampering its fight against increasingly sophisticated cheating.
 

Mixed results for malaria trial vaccine

New tests with a candidate malaria vaccine have shown it to be less effective in weeks-old infants than older babies, a "frustrating" result in the fight against the killer disease.
 

GlaxoSmithKline says Q3 net profits drop 18.5%

British drugmaker GlaxoSmithKline said Wednesday that third-quarter net profits fell 18.5 percent from a year earlier to £1.12 billion ($1.80 billion, 1.39 billion euros), hit by weak conditions in Europe.
 

London shares close higher

London shares closed higher on Tuesday, lifted by strong profits at oil giant BP as investors shrugged off the continued closure of Wall Street, dealers said.
 

London shares end lower as Wall Street stays shut

London shares closed lower amid renewed worries about Greek debt and in the absence of US investors with Wall Street closed because of Hurricane Sandy, dealers said.
 

FTSE rebounds on US jobs claims fall

London shares rebounded to end higher on Thursday, shrugging off Standard & Poor's slashing Spain's credit rating, and gaining added steam from a big drop in US jobs claims.
 

Swine flu vaccine linked to child narcolepsy: EU watchdog

A swine flu vaccine used in 2009-10 is linked to a higher risk of the sleeping disorder narcolepsy in children and teens in Sweden and Finland, the European Centre for Disease Prevention and Control said Friday.
 

Poor retail sales knock back US stocks

US stocks closed lower Monday after an unexpected fall in retail sales in June, the third consecutive drop that fueled concerns about the strength of consumer spending, a key driver of the economy.
 

Facts from the Wikipedia page:

GlaxoSmithKline
TypePublic (LSE: GSK
NYSEGSK)
Founded2000, by merger of Glaxo Wellcome and SmithKline Beecham
HeadquartersLondon, United Kingdom
Key peopleSir Chris Gent, Chairman
Andrew Witty, Chief Executive
Julian Heslop, Chief Financial Officer
Dr. Moncef Slaoui, Chairman of Research and Development
IndustryPharmaceutical
ProductsPharmaceuticals
Revenue£24.352 billion (2008)
Operating income£8.259 billion (2008)
Net income£4.712 billion (2008)
Employees103,000 (2008)[1]
Websitewww.gsk.com